Kaia Health raises $75m in Series C

Digital therapeutics provider Kaia Health has raised $75m in a Series C to help fuel expansion of its COPD and MSK services in Europe and the US. The latest funding round, which saw participation from an unnamed growth equity fund and existing investors, Optum Ventures, Eurazeo, 3VC, Balderton Capital, Heartcore Capital, Symphony Ventures and A Round Capital,…

You must be a HM Subscriber to view this content.

Subscribe Now »